Cystatin C is a small protein produced by virtually every cell in your body, and when its blood level runs high, the most common explanation is that your kidneys are not filtering as well as they should. Unlike creatinine, the older and more familiar kidney marker, cystatin C is not heavily influenced by muscle mass, which makes it a useful second opinion when kidney function is in question. But reduced kidney filtration is not the only reason cystatin C can climb. Obesity, corticosteroid use, thyroid problems, and chronic inflammation can all push levels up independently of how well your kidneys work, and understanding those causes matters for interpreting a result correctly.
What Cystatin C Actually Is
Cystatin C is a tiny protein, only about 13 kilodaltons, that belongs to a family of molecules whose main job is to inhibit certain enzymes called cysteine proteinases. All nucleated cells produce it at a relatively steady rate, which is part of why it appeals to clinicians as a filtration marker. Once it enters the bloodstream, cystatin C is freely filtered through the glomeruli in the kidneys and then almost completely reabsorbed and broken down by the cells lining the kidney tubules. Very little of it ends up in urine under normal circumstances.1Europe PMC. Cystatin C: not just a marker of kidney function Because of this process, the amount of cystatin C floating in your blood at any given time mostly reflects how quickly your kidneys are clearing it. When filtration slows, cystatin C accumulates and blood levels rise.
Why Doctors Order It Instead of (or Alongside) Creatinine
Creatinine has been the default kidney marker for decades, but it comes with blind spots. Creatinine is a breakdown product of creatine in muscle, so your level depends partly on how much muscle you carry, how much meat you eat, and how physically active you are. A lean older adult with shrinking muscle mass can have a deceptively normal creatinine level even though their kidneys are struggling. Research confirms that creatinine correlates strongly with lean body mass but cystatin C does not, making cystatin C a better gauge of kidney function in people at either extreme of the muscle spectrum.2PubMed Central. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C
This advantage is especially relevant for older adults, people who are bedridden or very sedentary, and those with conditions that cause muscle wasting. In these groups, creatinine-based estimates often overestimate how well the kidneys are working, potentially delaying diagnosis. On the flip side, very muscular individuals can have elevated creatinine that falsely suggests kidney trouble when their kidneys are fine. Cystatin C sidesteps that problem because its production is not tied to muscle.
A combined approach, using both markers together, tends to give the most accurate picture. Equations that incorporate both creatinine and cystatin C outperform equations using either marker alone, and they also reduce measurement disparities between racial groups.3PubMed Central. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race In a clinical case series, the combined equation most closely reflected the actual kidney diagnosis in all 16 patients reviewed, while creatinine alone frequently overestimated function in older or low-muscle patients and cystatin C alone sometimes showed lower values in people with inflammation or obesity.4PubMed Central. Comparison of Creatinine-, Cystatin C-, and Combined Creatinine–Cystatin C-Based Equations for Estimating Glomerular Filtration Rate
Kidney Disease Remains the Leading Cause
If your cystatin C comes back elevated, the first thing your doctor will consider is reduced kidney filtration, whether from chronic kidney disease, an acute injury, or something in between. This is statistically the most common explanation, and the protein’s biology makes the logic straightforward: fewer working filters in the kidney means less cystatin C gets cleared, so blood levels rise.
In acute kidney injury, cystatin C can flag a problem earlier than creatinine. One study found that more than half of patients experiencing acute kidney injury still had normal creatinine in the early phase, while every single one already showed elevated cystatin C.5PubMed Central. Serum cystatin C as a marker of renal function in detection of early acute kidney injury Emergency department research supports this pattern, showing cystatin C outperforms creatinine for early prediction of acute kidney injury in that fast-paced, mixed-patient setting.6PubMed Central. Cystatin C as a marker of acute kidney injury in the emergency department That head start can matter because earlier recognition of kidney injury allows doctors to intervene sooner, adjusting medications, managing fluid balance, or identifying the underlying trigger before more damage accumulates.
Diabetes and Early Kidney Damage
People with type 2 diabetes are at high risk for gradual kidney damage, and cystatin C has a particular niche here. Standard screening for diabetic kidney disease relies heavily on checking urine for albumin, a protein that leaks through when the kidney’s filtering membranes are damaged. But cystatin C can detect declining filtration even when albumin excretion still looks normal. In diabetic patients with normoalbuminuria, meaning their urine albumin levels had not yet flagged a problem, serum cystatin C was identified as an independent predictor of reduced kidney function.7PubMed Central. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes
One study examining patients with mildly reduced filtration found that over half had elevated cystatin C but no microalbuminuria, meaning cystatin C caught the problem while urine testing missed it entirely.8NefrologÃa (English Edition). Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages For people with diabetes who are being told their kidney tests are “fine” based only on creatinine and urine albumin, asking about cystatin C may reveal early trouble that warrants closer monitoring. The diagnostic accuracy of cystatin C for early kidney damage in type 2 diabetes has been reported around 86%, with sensitivity above 90%.9Life and Science. Diagnostic Accuracy of Serum Cystatin C for Early Detection of Kidney Damage in Patients with Type II Diabetes Mellitus
Obesity, Fat Tissue, and Metabolic Syndrome
Here is where the picture gets more complicated. Cystatin C is not just passively filtered by the kidneys; fat tissue actively produces it. Preadipocytes can express and release cystatin C, and both subcutaneous and visceral fat overexpress the protein in living tissue. This means cystatin C partly functions as an adipokine, a signaling molecule secreted by fat.10Revista Portuguesa de Cardiologia. Clinical analysis of the relationship between cystatin C and metabolic syndrome in the elderly In a person carrying significant excess weight, some portion of an elevated cystatin C level may reflect increased production by fat cells rather than impaired kidney clearance.
A large prospective study following participants over time found that higher baseline cystatin C levels predicted the future development of metabolic syndrome, with abdominal obesity being the component most strongly linked to rising cystatin C.11Journal of Internal Medicine. High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study Cystatin C also correlates with visceral adiposity indexes and markers of blood vessel disease risk in people with metabolic syndrome.12PubMed. Proportional correlates of cystatin-C with pentraxin-3, visceral adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients with and without prediabetes For clinicians, this means an elevated cystatin C in an obese patient needs careful interpretation. The kidneys may be fine, or they may be subtly declining, with obesity inflating the number further.
Corticosteroids Can Raise Cystatin C Without Harming the Kidneys
If you are taking prednisone, dexamethasone, or another corticosteroid, your cystatin C level may go up even if your kidneys are working perfectly. Animal studies have shown that corticosteroids boost cystatin C production across multiple organs, including the kidneys, brain, liver, intestines, and lungs, all without changing the actual rate of kidney filtration. This effect was blocked by a glucocorticoid receptor antagonist, confirming that it is a direct hormonal response rather than kidney damage.13PubMed Central. Corticosteroids significantly increase cystatin C levels in the plasma by promoting cystatin C production in rats
The same pattern shows up in people. In patients with symptomatic heart failure who were given prednisone, cystatin C levels rose significantly over the treatment period, but the increase was not associated with any actual decline in kidney function.14PubMed. Corticosteroids Significantly Increase Serum Cystatin C Concentration without Affecting Renal Function in Symptomatic Heart Failure This is a genuinely important clinical pitfall. A doctor who sees a rising cystatin C in a patient recently started on steroids might wrongly assume the kidneys are failing. The steroid effect needs to be considered before changing treatment plans.
Thyroid Dysfunction
Thyroid hormones also influence cystatin C levels in ways that have nothing to do with filtration. In patients with hypothyroidism on levothyroxine therapy, those with suboptimal thyroid hormone levels (meaning their TSH was still elevated, indicating undertreatment) had significantly higher cystatin C than well-controlled patients, even though their actual measured kidney filtration rates and creatinine levels were identical between groups. TSH and cystatin C showed a strong positive correlation.15PubMed Central. Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy
The practical implication is that someone with poorly controlled hypothyroidism can appear to have worse kidney function on a cystatin C-based estimate than they actually do. If hypothyroidism is being treated and the dosage has recently changed, a cystatin C test should be interpreted with caution until thyroid levels stabilize. This is another situation where comparing cystatin C-based and creatinine-based kidney function estimates can reveal a discrepancy that points to a non-kidney explanation.
Cardiovascular Risk and Cystatin C
Beyond its role as a kidney marker, cystatin C has emerged as a predictor of heart disease and death, even after accounting for traditional risk factors and kidney function itself. A meta-analysis pooling data from predominantly high-risk populations found that people in the highest cystatin C category had roughly two and a half times the risk of cardiovascular disease compared to those in the lowest category. Each standard deviation increase in cystatin C was linked to about a 34% higher risk of cardiovascular events.16PubMed. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis
In a long-term follow-up study of patients with stable coronary heart disease, those in the highest quarter of cystatin C levels had roughly 37% higher risk of the combined endpoint of coronary death or heart attack, and this association remained significant even after adjusting for kidney function estimated by both creatinine and cystatin C combined. The link to cardiovascular and all-cause death persisted over 16 years of follow-up.17PubMed Central. Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease
The crucial question is whether cystatin C is merely a marker of cardiovascular risk or whether it actively contributes to heart disease. A Mendelian randomization study, which uses genetic variation to test whether a relationship is likely causal, found no evidence that cystatin C itself plays a causal role in cardiovascular disease. That means lowering cystatin C directly would probably not prevent heart attacks or strokes.18PubMed Central. Cystatin C and Cardiovascular Disease A Mendelian Randomization Study Instead, elevated cystatin C likely reflects the cluster of underlying problems, kidney dysfunction, inflammation, obesity, metabolic stress, that drive cardiovascular disease. It is a thermometer, not the fever.
Links to Mortality Beyond Heart Disease
The association between high cystatin C and death extends beyond cardiovascular events. In a diverse cohort of middle-aged and older adults, a 10% increase in cystatin C was associated with a substantially increased risk of all-cause mortality, and this held true across follow-up visits.19PLoS ONE. Serum Cystatin-C is linked to increased prevalence of diabetes and higher risk of mortality in diverse middle-aged and older adults This kind of broad mortality association makes cystatin C an interesting biomarker for overall health status. An elevated level in a person without obvious kidney disease may signal low-grade systemic trouble, whether metabolic, inflammatory, or vascular, that warrants a closer look rather than dismissal.
Age, Sex, and Smoking
Cystatin C levels are not static across populations. Age is the strongest non-kidney influence: levels rise steadily with aging, estimated at roughly 0.015 mg/L per year in one study of older adults without diabetes.20Age and Ageing. Male sex and vascular risk factors affect cystatin C-derived renal function in older people without diabetes or overt vascular disease This reflects both gradual kidney aging and potentially increased production by other tissues.
Sex differences exist but vary by age. A systematic review and meta-analysis found that younger and middle-aged men have about 8 to 9% higher cystatin C concentrations than women. This gap emerges during adolescence, likely driven by hormonal and body-composition changes, and narrows progressively after age 60.21PubMed. The sex difference in plasma cystatin C is age-dependent: a systematic review and meta-analysis In healthy volunteers, smoking was associated with slightly higher levels, though the difference was not statistically significant.22PubMed. Influence of age, gender, smoking, diabetes, thyroid and cardiac dysfunctions on cystatin C biomarker Smoking likely matters more in people who already have vascular or inflammatory disease, where it amplifies the non-kidney contributors to elevated cystatin C.
Shrunken Pore Syndrome
When cystatin C-based kidney function estimates come in dramatically lower than creatinine-based estimates, and no obvious non-kidney explanation accounts for the gap, doctors sometimes invoke a condition called shrunken pore syndrome. The idea is that the tiny pores in the glomerular filtration barrier have become selectively narrower, restricting the passage of small-to-mid-sized proteins like cystatin C more than very small molecules like creatinine. The condition is defined by a cystatin C-based filtration estimate that falls below 60 to 70% of the creatinine-based estimate, once confounders like steroid use or thyroid dysfunction have been ruled out.23PubMed. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities
This syndrome is still an emerging concept and not universally accepted, but research has linked it to increased mortality risk. It may help explain why some patients have persistently high cystatin C with only mildly abnormal creatinine and no clear metabolic or hormonal cause. If your doctor mentions a large discrepancy between your two kidney function estimates, shrunken pore syndrome is one possibility they might explore.
Pregnancy and Preeclampsia
Pregnancy naturally changes kidney filtration, increasing it substantially to handle the metabolic demands of carrying a fetus. Cystatin C levels during pregnancy reflect these changes, and an unexpected rise in cystatin C during the third trimester can be an early warning of preeclampsia, a dangerous complication involving high blood pressure and organ damage. Research shows cystatin C has strong diagnostic performance for preeclampsia, with sensitivity around 88% and specificity above 98% in one study, outperforming both creatinine and uric acid for detecting the kidney involvement that characterizes the condition.24PubMed Central. Cystatin-C as a Marker for Renal Impairment in Preeclampsia A meta-analysis of 27 studies concluded that cystatin C appears to be a promising biomarker for detecting preeclampsia, particularly in the third trimester.25PubMed. Serum cystatin-c as predictive factor of preeclampsia: A meta-analysis of 27 observational studies
For pregnant women, a high cystatin C finding carries different diagnostic weight than it does for the general population. The result needs to be read in the context of the normal pregnancy-related increase in filtration and compared against trimester-specific reference ranges rather than standard adult values.
Cystatin C and the Brain
Cystatin C is expressed in the brain, and altered levels have been linked to neurological conditions, most prominently Alzheimer’s disease. Changes in cystatin C expression and secretion are observed in various neurodegenerative disorders, and a genetic variant in the cystatin C gene has been associated with increased Alzheimer’s risk.26PubMed Central. Cystatin C in Alzheimer’s disease Whether cystatin C in the brain is protective, harmful, or both likely depends on the context. In its role as an enzyme inhibitor, cystatin C may help limit tissue damage caused by unchecked proteinase activity. But these relationships are still being untangled, and measuring blood cystatin C is not currently used as a screening tool for dementia risk.
Accuracy Gaps Between Racial Groups
One of the reasons cystatin C gained traction in recent years is the push to remove race from kidney function equations. Older creatinine-based formulas included a race coefficient that adjusted results for Black patients, a practice that was both scientifically and ethically controversial. Adding cystatin C to the equation helped reduce the need for that adjustment. Still, accuracy disparities have not been fully eliminated. A systematic review and meta-analysis found that even with combined creatinine-cystatin C equations, the proportion of estimates falling within 30% of measured kidney function was lower for Black individuals than for non-Black individuals.27JAMA Network Open. Bias and Accuracy of Glomerular Filtration Rate Estimating Equations in the US: A Systematic Review and Meta-Analysis The combined equation is an improvement, but the science of kidney function estimation is still a work in progress, and no single equation performs equally well in everyone.
Lab Considerations That Can Muddy the Water
How the lab measures cystatin C also matters. Two main types of assay exist for this test: particle-enhanced nephelometric and turbidimetric immunoassays. They do not always agree perfectly. Turbidimetric assays have historically shown higher variability at concentrations near the upper limit of normal, and they can be affected by very high levels of bilirubin, hemoglobin from a hemolyzed sample, or triglycerides in the blood. If a sample is lipemic (visibly milky from high fat) or hemolyzed (with broken red blood cells), the cystatin C result may be unreliable. Labs have worked to standardize cystatin C measurement against an international reference material, but if your result seems inconsistent with your clinical picture, asking whether the sample quality might be a factor is reasonable.
When a High Result Is Not About the Kidneys at All
Pulling together the non-kidney influences, here are the situations where an elevated cystatin C may be misleading if interpreted purely as a kidney marker:
- Corticosteroid use: Prednisone, dexamethasone, and related drugs increase cystatin C production across multiple tissues without reducing kidney function.
- Underactive thyroid: Poorly controlled hypothyroidism elevates cystatin C independently of filtration rate.
- Significant obesity: Fat tissue overexpresses cystatin C, so excess body fat can inflate the level beyond what kidney function alone would explain.
- Systemic inflammation: Chronic inflammatory states may raise cystatin C, which is part of why the marker correlates with cardiovascular risk even after adjusting for measured kidney function.
None of these mean the result should be ignored. A high cystatin C in the setting of obesity or chronic inflammation could genuinely reflect early kidney trouble on top of the extra production. The point is that interpretation should account for the full clinical picture rather than treating cystatin C as a pure kidney readout. The most reliable approach is to compare cystatin C-based and creatinine-based kidney function estimates side by side, flag any large discrepancy, and then work through the list of non-kidney influences to figure out what is actually going on.4PubMed Central. Comparison of Creatinine-, Cystatin C-, and Combined Creatinine–Cystatin C-Based Equations for Estimating Glomerular Filtration Rate